{{Rsnum
|rsid=11155313
|Gene=PHACTR2
|Chromosome=6
|position=143640440
|Orientation=plus
|GMAF=0.2525
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=PHACTR2
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 45.3 | 40.6 | 14.1
| HCB | 66.7 | 28.9 | 4.4
| JPT | 54.5 | 43.2 | 2.3
| YRI | 46.0 | 47.6 | 6.3
| ASW | 0.0 | 0.0 | 0.0
| CHB | 66.7 | 28.9 | 4.4
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}
Four case-control series were combined along with previous GWAS results, yielding a 1.3x increased risk for [[Parkinson's disease]] among [[rs11155313]] minor allele carriers.{{PMID|19429005|OA=1
}}

{{PMID Auto
|PMID=16252231
|Title=High-resolution whole-genome association study of Parkinson disease.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}